Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
Stem Cells. 2010 Oct;28(10):1848-55. doi: 10.1002/stem.493.
Vitamin C (ascorbate) is a widely used medium supplement in embryonic stem cell culture. Here, we show that ascorbate causes widespread, consistent, and remarkably specific DNA demethylation of 1,847 genes in human embryonic stem cells (hESCs), including important stem cell genes, with a clear bias toward demethylation at CpG island boundaries. We show that a subset of these DNA demethylated genes displays concomitant gene expression changes and that the position of the demethylated CpGs relative to the transcription start site is correlated to such changes. We further show that the ascorbate-demethylated gene set not only overlaps with gene sets that have bivalent marks, but also with the gene sets that are demethylated during differentiation of hESCs and during reprogramming of fibroblasts to induced pluritotent stem cells (iPSCs). Our data thus identify a novel link between ascorbate-mediated signaling and specific epigenetic changes in hESCs that might impact on pluripotency and reprogramming pathways.
维生素 C(抗坏血酸)是胚胎干细胞培养中广泛使用的培养基补充剂。在这里,我们表明抗坏血酸导致人类胚胎干细胞(hESC)中 1847 个基因的广泛、一致且非常特异的 DNA 去甲基化,包括重要的干细胞基因,并且在 CpG 岛边界处偏向于去甲基化。我们表明,这些去甲基化的 DNA 基因的一部分显示出伴随的基因表达变化,并且去甲基化的 CpG 相对于转录起始位点的位置与这些变化相关。我们进一步表明,抗坏血酸去甲基化基因集不仅与具有二价标记的基因集重叠,而且与 hESC 分化过程中和成纤维细胞重编程为诱导多能干细胞(iPSC)过程中去甲基化的基因集重叠。因此,我们的数据确定了抗坏血酸介导的信号转导与 hESC 中特定表观遗传变化之间的新联系,这可能影响多能性和重编程途径。